Hematologic changes are frequent complications in people living with HIV/AIDS (PLWHA).
Anemia and thrombocytopenia are the most frequent multifactorial hematologic …

Human immunodeficiency virus (HIV) infection not only leads to a compromised immune
system, but also disrupts normal haematopoiesis, resulting in the frequent manifestation of …

Anemia in HIV-infected patients improves with highly active antiretroviral therapy (HAART);
however, it may still be associated with mortality among patients receiving treatment. We …

Background. Globally, anemia, among people living with HIV/AIDS, is a major public health
problem. It has a significant effect on the progression of HIV/AIDS to advanced stages and …

Background Human immunodeficiency virus and anemia are the major public health
problems in Sub-Sahara Africa. Untreated anemia is associated with rapid progression and …

Background In Sub-Saharan Africa, both HIV/AIDS and anemia have considerable public
health problems. Anemia has an adverse effect on treatment outcome and it decreases the …

Background Anaemia is frequently associated with both HIV-infection and HIV-related
tuberculosis (TB) in antiretroviral therapy (ART)-naïve patients in sub-Saharan Africa and is …

Background Anemia is a major public health problem in HIV patients around the world. It has
a negative effect on the quality of life of HIV patients and progression of the HIV disease. In …

Background: Hematological complications such as Zidovudine (ZDV) associated anemia are
among the commonly reported adverse drug reactions of Antiretroviral Therapy (ART). Little …

Background Anemia is a major public health problem worldwide which accounts 24.8% of
the population. Subsequently, anemia is a leading killer of people living with human …